ContextVision AB
OSE:CONTX

Watchlist Manager
ContextVision AB Logo
ContextVision AB
OSE:CONTX
Watchlist
Price: 3.7 NOK -4.39% Market Closed
Market Cap: 286.3m NOK
Section:
 

Relative Value

The Relative Value of one CONTX stock under the Base Case scenario is 5.2 NOK. Compared to the current market price of 3.7 NOK, ContextVision AB is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CONTX Relative Value
Base Case
5.2 NOK
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
98
vs Industry
34
Median 3Y
3.5
Median 5Y
5.4
Industry
2.4
Forward
2.4
More Details
73.1
P/E
P/E
Price to Earnings
73.1
vs History
12
vs Industry
28
Median 3Y
18.7
Median 5Y
18.2
Industry
22.9
Forward
-328.3
More Details
29.5
P/OCF
P/OCF
Price to OCF
29.5
vs History
42
vs Industry
26
Median 3Y
15.4
Median 5Y
25.5
Industry
14.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
26
Median 3Y
16.5
Median 5Y
26.5
Industry
21.4
More Details
2.9
P/B
P/B
Price to Book Value
2.9
vs History
98
vs Industry
17
Median 3Y
5.1
Median 5Y
8.9
Industry
2.3
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
98
vs Industry
39
Median 3Y
3
Median 5Y
5
Industry
2.6
Forward
1.8
More Details
1.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.8
vs History
98
vs Industry
60
Median 3Y
3.1
Median 5Y
4.9
Industry
5.3
More Details
18
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
18
vs History
30
vs Industry
33
Median 3Y
11.5
Median 5Y
13
Industry
12.3
Forward
9.3
More Details
61.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
61.1
vs History
6
vs Industry
32
Median 3Y
13.7
Median 5Y
16.5
Industry
17.2
Forward
242.8
More Details
22.5
EV/OCF
EV/OCF
Enterprise Value to OCF
22.5
vs History
47
vs Industry
33
Median 3Y
14
Median 5Y
24
Industry
15
More Details
119.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
119.6
vs History
25
vs Industry
34
Median 3Y
17
Median 5Y
39.5
Industry
19
More Details
4.1
EV/IC
EV/IC
Enterprise Value to IC
4.1
vs History
98
vs Industry
9
Median 3Y
8.7
Median 5Y
10.9
Industry
1.9
More Details

Multiples Across Competitors

CONTX Competitors Multiples
ContextVision AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
ContextVision AB
OSE:CONTX
286.3m NOK 2.3 73.1 18 61.1
US
Veeva Systems Inc
NYSE:VEEV
37.4B USD 12.1 43.4 33.1 34.5
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
22.2B AUD 100.6 192.6 133 133
JP
M3 Inc
TSE:2413
1.4T JPY 4.3 31 15.8 19.4
US
Doximity Inc
NYSE:DOCS
7.8B USD 12.5 30.7 26.7 28
US
Waystar Holding Corp
NASDAQ:WAY
5.3B USD 5.1 48 16.1 25.2
SE
Sectra AB
STO:SECT B
45.1B SEK 20.2 69.7 -137.7 -137.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32.6B CNY 15.1 -105.8 -209 -209
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
292.1B INR 11 60.1 37.4 43.6
US
Vocera Communications Inc
F:V00
2.4B EUR 11.9 -328.9 268.6 4 301.1
P/E Multiple
Earnings Growth PEG
SE
ContextVision AB
OSE:CONTX
Average P/E: 66.9
73.1
-9%
N/A
US
Veeva Systems Inc
NYSE:VEEV
43.4
32%
1.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
192.6
32%
6
JP
M3 Inc
TSE:2413
31
16%
1.9
US
Doximity Inc
NYSE:DOCS
30.7
18%
1.7
US
W
Waystar Holding Corp
NASDAQ:WAY
48
N/A N/A
SE
Sectra AB
STO:SECT B
69.7
17%
4.1
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -105.8
92%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
60.1
31%
1.9
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
ContextVision AB
OSE:CONTX
Average EV/EBITDA: 63.4
18
-3%
N/A
US
Veeva Systems Inc
NYSE:VEEV
33.1
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
133
32%
4.2
JP
M3 Inc
TSE:2413
15.8
14%
1.1
US
Doximity Inc
NYSE:DOCS
26.7
23%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
16.1
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -137.7 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -209
36%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
37.4
24%
1.6
US
V
Vocera Communications Inc
F:V00
268.6
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
ContextVision AB
OSE:CONTX
Average EV/EBIT: 521
61.1
-10%
N/A
US
Veeva Systems Inc
NYSE:VEEV
34.5
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
133
31%
4.3
JP
M3 Inc
TSE:2413
19.4
N/A N/A
US
Doximity Inc
NYSE:DOCS
28
25%
1.1
US
W
Waystar Holding Corp
NASDAQ:WAY
25.2
58%
0.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -137.7 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -209
47%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
43.6
26%
1.7
US
V
Vocera Communications Inc
F:V00
4 301.1
N/A N/A

See Also

Summary
CONTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CONTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CONTX stock valuation using valuation multiples.
Wall Street Estimates
CONTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CONTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.